|
|
Volumn , Issue , 2009, Pages 453-460
|
|
Initial treatment for patients with CML.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA INTERFERON;
ANTINEOPLASTIC AGENT;
BCR ABL PROTEIN;
CYTOSTATIC AGENT;
IMATINIB;
PIPERAZINE DERIVATIVE;
PROTEIN KINASE INHIBITOR;
PYRIMIDINE DERIVATIVE;
TUMOR MARKER;
ADULT;
ALLOTRANSPLANTATION;
BLOOD;
CHRONIC MYELOID LEUKEMIA;
DRUG MONITORING;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
MALE;
MYELOID LEUKEMIA;
PATIENT SELECTION;
PRACTICE GUIDELINE;
PREGNANCY;
PREGNANCY COMPLICATION;
REVIEW;
SURVIVAL;
ADULT;
ANTINEOPLASTIC AGENTS;
CYTOSTATIC AGENTS;
DRUG MONITORING;
FEMALE;
FUSION PROTEINS, BCR-ABL;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
INTERFERON-ALPHA;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
LEUKEMIA, MYELOID, ACCELERATED PHASE;
LEUKEMIA, MYELOID, CHRONIC-PHASE;
MALE;
PATIENT SELECTION;
PIPERAZINES;
PRACTICE GUIDELINES AS TOPIC;
PREGNANCY;
PREGNANCY COMPLICATIONS, HEMATOLOGIC;
PROTEIN KINASE INHIBITORS;
PYRIMIDINES;
SURVIVAL ANALYSIS;
TRANSPLANTATION, HOMOLOGOUS;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 77949481924
PISSN: None
EISSN: 15204383
Source Type: Journal
DOI: 10.1182/asheducation-2009.1.453 Document Type: Review |
|
Times cited : (39)
|
|
References (47)
|
